PTC THERAPEUTICS INC (PTCT)
US69366J2006 - Common Stock
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 548.36M | 594.00M | 279.80M | 189.70M | 208.80M | |||
| Marketable Securities | 336.46M | 282.74M | 130.90M | 583.70M | 894.80M | |||
| Receivables | 197.66M | 160.82M | 155.60M | 110.50M | 69.90M | |||
| Inventories | 30.06M | 30.58M | 21.80M | 15.90M | 18.70M | |||
| Other Current Assets | 56.21M | 150.49M | 105.70M | 54.70M | 39.50M | |||
| Total Current Assets | 1.17B | 1.22B | 693.80M | 954.40M | 1.23B | |||
| Non-Current Assets | ||||||||
| PPE Net | 183.97M | 178.99M | 175.00M | 130.00M | 118.20M | |||
| Goodwill | 82.34M | 82.34M | 82.30M | 82.30M | 82.30M | |||
| Intangibles | 330.04M | 379.50M | 705.90M | 724.80M | 715.30M | |||
| Other Non-Current Assets | 24.55M | 36.25M | 48.60M | 46.50M | 60.60M | |||
| Total Non-Current Assets | 620.89M | 677.07M | 1.01B | 983.70M | 976.60M | |||
| TOTAL ASSETS | 1.79B | 1.90B | 1.71B | 1.94B | 2.21B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 229.05M | 197.31M | 75.10M | 211.80M | 22.30M | |||
| Accrued Expenses | 88.13M | 116.32M | 126.10M | 105.60M | 92.00M | |||
| Accounts Payable | 94.53M | 83.22M | 91.10M | 84.70M | 73.00M | |||
| Other Current Liabilities | 162.83M | 206.25M | 114.00M | 107.20M | 90.10M | |||
| Total Current Liabilities | 574.55M | 603.10M | 406.20M | 509.30M | 277.30M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 1.91B | 1.92B | 1.28B | 976.60M | 990.90M | |||
| Deferred Taxes/Income | 55.90M | 55.91M | 102.80M | 137.10M | 136.70M | |||
| Other Non-Current Liabilities | 141.18M | 134.07M | 267.50M | 313.50M | 321.30M | |||
| Total Non-Current Liabilities | 2.11B | 2.11B | 1.65B | 1.43B | 1.45B | |||
| TOTAL LIABILITIES | 2.68B | 2.71B | 2.05B | 1.94B | 1.73B | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -3.38B | -3.28B | -2.66B | -2.10B | -1.63B | |||
| Additional Paid In Capital | 2.49B | 2.47B | 2.31B | 2.12B | 2.17B | |||
| Common Shares | 76.00K | 75.00K | 100.00K | 100.00K | 100.00K | |||
| Other Shareholders' Equity | -5.56M | -1.61M | 5.30M | -23.70M | -62.90M | |||
| Shares Outstanding | 76.65M | 75.71M | 73.10M | 70.80M | 69.70M | |||
| Tangible Book Value per Share | -17.04 | -16.91 | -15.53 | -11.38 | -4.53 | |||
| Total Shareholders' Equity | -893.92M | -818.55M | -347.10M | 1.40M | 482.00M | |||
| TOTAL LIABILITIES AND EQUITY | 1.79B | 1.90B | 1.71B | 1.94B | 2.21B | |||
| Statistics | ||||||||
| Debt/Equity | -2.14 | -2.35 | -3.68 | 697.57 | 2.06 | |||
| Current Ratio | 2.03 | 2.02 | 1.71 | 1.87 | 4.44 | |||
| Return On Assets (ROA) | -32.37% | -33.05% | -32.77% | -27.03% | -19.84% | |||
| Return On Equity (ROE) | N/A | N/A | N/A | -37421.43% | -90.91% | |||
All data in USD